Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2024 Earnings Call Transcript March 6, 2025 Atea Pharmaceuticals, Inc. misses on ...

And it's based on one of the all-time classic time-killing activities: doodling. Quick, Draw!, which is just one of the features in Google's new A.I. Experiments initiative, gives players a ...

Atea Pharmaceuticals has already laid off a quarter of its workforce so far this year as the biotech prepares to launch a phase 3 trial of its hepatitis C cocktail. The treatment—a combination ...

BOSTON, March 06, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral ...

Good afternoon, everyone, and welcome to the Atea Pharmaceuticals' Fourth Quarter 2024 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.

Atea Pharmaceuticals Inc. reported its Q4 2024 earnings, revealing a wider-than-expected loss per share, which impacted the company’s stock performance. The earnings per share (EPS) came in at ...

BOSTON, March 06, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral ...

Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on AVIR: Atea Pharmaceuticals NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.